⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

European Stocks Lower; Carrefour Slumps as Takeover Pulled

Published 18/01/2021, 08:25
© Reuters.
EUR/USD
-
UK100
-
XAU/USD
-
FCHI
-
DE40
-
CARR
-
BT
-
SEVI
-
GC
-
LCO
-
CL
-
VEOEY
-
AZN
-

By Peter Nurse 

Investing.com - European stock markets edged lower Monday, starting the week on a downbeat note given Covid-related concerns, and not reassured by healthy-looking Chinese economic growth.

At 3:30 AM ET (0830 GMT), the DAX in Germany traded 0.2% lower, the CAC 40 in France fell 0.3% and the U.K.'s FTSE index dropped 0.1%. 

China reported Monday that its economy grew 2.3% last year, as its gross domestic product rose by 6.5% in the fourth quarter from a year ago, helped by retail sales rising 4.6% in the final quarter from a year ago.

The figures from the world’s second largest economy have tended to be overshadowed by worries about the impact of the latest surge in Covid-19 cases, especially in Europe but also further afield.

China has recently locked down over 28 million people to combat the virus. In Europe, opposition to the latest restrictions is growing, as several thousand people held an unauthorized protest in Amsterdam on Sunday before being dispersed by riot police. While, in the U.S., the spread of the coronavirus has hit consumer spending, given Friday’s weak retail sales.

Still, losses are limited in Europe Monday, with the U.S. on holiday, and ahead of the latest European Central Bank meeting on Thursday.

Investors will also be keeping a wary eye on events in Washington, amid concerns about possible violence at President-elect Joe Biden’s inauguration on Wednesday as well as how much of his proposed $1.9 trillion stimulus plan will get through Congress given Republican opposition.

Back in Europe, Carrefour (PA:CARR) stock slumped 6.5% after the Canadian company Couche-Tard abandoned its attempted takeover of the French retail giant after opposition from the French government.

Suez (PA:SEVI) stock climbed 2.6% after the French water company received an alternative offer from private equity firms Ardian and Global Infrastructure Partners, giving it an option aside from the takeover attempt by rival Veolia Environnement (OTC:VEOEY).

AstraZeneca (NASDAQ:AZN) stock rose 0.3% as the drug maker received U.S. approval for its gastric cancer drug, while BT Group (LON:BT) stock fell 2.9% as it faces a class action lawsuit over claims it failed to compensate elderly customers who were overcharged for landlines for years.

Oil prices fell Monday as rising Covid-19 cases, particularly in China, the world’s largest crude importer, called into question the recent recovery in demand.

U.S. crude futures traded 0.8% lower at $51.99 a barrel, while the international benchmark Brent contract fell 0.9% to $54.59. Both benchmarks declined by more than 2% on Friday.

Elsewhere, gold futures rose 0.2% to $1,833.60/oz, while EUR/USD traded 0.1% lower at 1.2073.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.